To include your compound in the COVID-19 Resource Center, submit it here.

EMA's CHMP recommends Samsung's Herceptin biosimilar

EMA’s CHMP backed approval of Ontruzant (SB3) from Samsung Bioepis

Read the full 101 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE